Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nagaileben Co., Ltd. ( (JP:7447) ) has issued an announcement.
For the three months ended November 30, 2025, Nagaileben reported a 9.0% year-on-year decline in net sales to ¥2,920 million and a sharper drop in profitability, with operating profit down 28.8% to ¥412 million and profit attributable to owners of parent down 23.2% to ¥317 million, while total assets and equity also decreased slightly but the equity ratio remained above 90%. The company kept its previous guidance unchanged, forecasting a recovery for the fiscal year ending August 31, 2026, with net sales expected to grow 6.0% to ¥18,000 million and profit attributable to owners of parent to rise 12.7% to ¥2,900 million, alongside a planned reduction in the annual dividend to ¥60 per share following the inclusion of a one-off commemorative dividend in the prior year, signaling a normalization of shareholder returns and expectations of moderate earnings growth despite the weak first quarter.
More about Nagaileben Co., Ltd.
Nagaileben Co., Ltd. is a Tokyo Stock Exchange-listed Japanese company operating under Japanese GAAP, primarily engaged in the manufacture and sale of professional apparel and related products, with a focus on the medical and healthcare fields. The company serves institutional customers and maintains a strong equity base with a high equity-to-asset ratio, reflecting a conservative financial structure.
Average Trading Volume: 101,408
Technical Sentiment Signal: Sell
Current Market Cap: Yen49.03B
For an in-depth examination of 7447 stock, go to TipRanks’ Overview page.